ArticleJAMA internal medicine2019

Assessment of Use of Combined Dextromethorphan and Quinidine in Patients With Dementia or Parkinson Disease After US Food and Drug Administration Approval for Pseudobulbar Affect.

Michael Fralick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.